Skip to main content
. 2021 Nov 28;13(23):5991. doi: 10.3390/cancers13235991

Figure 5.

Figure 5

Evolution the target coverage (D98) for high-risk (HR) and low-risk (LR) CTVs and all the scenarios tested for a chosen patient.